Using in vivo, ex vivo, and in vitro models, we now show that the mechanism of sustained hyperinsulinemia in the setting of FATP2 inhibition or deletion was α cell–mediated GLP-1 secretion with paracrine stimulation of β cell insulin secretion. This evidence concerns the gene SLC27A2 and hyperinsulinism.